NCT02165293View on ClinicalTrials.gov

A Single Center Study to Evaluate the Penetration of RO7033877 Into the Lung in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

June 30, 2014

Primary Completion Date

September 30, 2014

Study Completion Date

September 30, 2014

Conditions
Healthy Volunteer
Interventions
DRUG

RO7033877 + Bronchoscopy

Days 1, 2, and 3: 2.5 mg/kg RO7033877 infused IV over 2 hours, every 8 hours for a total of 7 doses; BAL procedure on Day 3.

Trial Locations (1)

85006

Phoenix

All Listed Sponsors
lead

Hoffmann-La Roche

INDUSTRY

NCT02165293 - A Single Center Study to Evaluate the Penetration of RO7033877 Into the Lung in Healthy Volunteers | Biotech Hunter | Biotech Hunter